As of the cutoff date, June 25, 2024, 39 patients have been enrolled in the ongoing Phase 1 clinical trial across five dose levels of ELVN-001, ranging from 10 mg once daily (QD) to 120 mg QD, and the ...

Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $1.9 million, or ...

The Proposed Transaction is planned to be completed by way of a three-cornered merger pursuant to which, a wholly owned subsidiary of the Company incorporated in Nevada will merge with 3Win and 3Win ...

OTTAWA, Ontario, Sept. 28, 2024 (GLOBE NEWSWIRE) -- As the world observes International Safe Abortion Day, the Society of Obstetricians and Gynaecologists of Canada (SOGC) is reaffirming its ...

The company expects to submit the new 510 (k) application in the coming quarter and will provide updates on its progress in the regulatory process, as appropriate.

Webcast to be held Monday, September 23, at 8:00 a.m. ET ...

Poster Presentation American Rhinologic Society (ARS) 2024 Annual Meeting Title: Efficacy and safety of LYR-210 for CRS from the pivotal Phase 3 ENLIGHTEN 1 trial Presenting Author: Vineeta Belanger, ...

Total number of securities carrying voting rights: 34,389,015 (all ordinary shares) Total number of voting rights (= denominator): 34,389,015 (all relating to ordinary shares) ...

ImPact Biotech shared interim results at the American Society of Clinical Oncology 2024 in June in which 10 of the 13 (77%) response-evaluable patients achieved a CR at the end of ITP. The company is ...

The pre-funded warrants and the warrants will be exercisable upon shareholder approval. The pre-funded warrants will be exercisable at a price of $0.0001 per share until exercised in full. The ...

Nexstim’s Diagnostics Business focuses on commercialization of the Navigated Brain Stimulation (NBS) system. The NBS System 5 is the only FDA cleared and CE marked navigated TMS system for presurgical ...

About Dupixent Dupixent is available in China in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available for COPD. Dupixent is intended for injection under the skin (subcutaneous ...